Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled furosemide for acute asthma attack
IRCT20180522039784N2Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of furosemide in asthma (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: FEV1 and PEFR. Started Dec 2021; status: completed.
02
Drugs
furosemide
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20180522039784N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180522039784N2.